Stay updated on Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial
Sign up to get notified when there's something new on the Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial page.

Latest updates to the Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial page
- Check6 days agoChange DetectedThe page now shows Revision: v3.5.4 in the footer, replacing the previous Revision: v3.5.3 to reflect the current version.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThis updates the website software/version indicator for the study details page (Revision v3.5.3 instead of v3.5.2) without changing the displayed clinical trial content.SummaryDifference0.1%

- Check34 days agoChange Detected- Revision: v3.5.2 updated from v3.5.0.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Hepatocellular carcinoma term and a Genetic and Rare Diseases Information Center resource. Updated site version from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check70 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision: v3.4.2 is now displayed. The earlier v3.4.1 notice about government funding and operating status has been removed.SummaryDifference0.4%

Stay in the know with updates to Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial page.